Clinical Trial Update: Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and tolerability of a five-drug regimen (bedaquiline, delamanid, levofloxacin, linezolid, and clofazimine) for multidrug-r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis

Drugs mentioned

• Deltyba (delamanid) (delamanid)
• Lamprene (clofazimine) (clofazimine)
• Levaquin (levofloxacin) (levofloxacin)
• Sirturo (bedaquiline) (bedaquiline)
• Zyvox (linezolid) (linezolid)

Snippet

Sponsor: Boston University | Conditions: Tuberculosis, Multidrug-Resistant | Phase 2 | Status: ACTIVE_NOT_RECRUITING